Comparison of the pharmacokinetics of an oral extended-release capsule formulation of carbidopa-levodopa (IPX066) with immediate-release carbidopa-levodopa (Sinemet(®)), sustained-release carbidopa-levodopa (Sinemet(®) CR), and carbidopa-levodopa-entacapone (Stalevo(®)).

Saved in:
Bibliographic Details
Title: Comparison of the pharmacokinetics of an oral extended-release capsule formulation of carbidopa-levodopa (IPX066) with immediate-release carbidopa-levodopa (Sinemet(®)), sustained-release carbidopa-levodopa (Sinemet(®) CR), and carbidopa-levodopa-entacapone (Stalevo(®)).
Authors: Hsu A; Impax Specialty Pharma, a division of Impax Laboratories, Inc., Hayward, CA, USA., Yao HM; Impax Specialty Pharma, a division of Impax Laboratories, Inc., Hayward, CA, USA., Gupta S; Impax Specialty Pharma, a division of Impax Laboratories, Inc., Hayward, CA, USA., Modi NB; Impax Specialty Pharma, a division of Impax Laboratories, Inc., Hayward, CA, USA.
Source: Journal of clinical pharmacology [J Clin Pharmacol] 2015 Sep; Vol. 55 (9), pp. 995-1003. Date of Electronic Publication: 2015 May 20.
Publication Type: Journal Article; Randomized Controlled Trial
Journal Info: Publisher: Wiley Country of Publication: England NLM ID: 0366372 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1552-4604 (Electronic) Linking ISSN: 00912700 NLM ISO Abbreviation: J Clin Pharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1552-4604
DOI:10.1002/jcph.514